The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C

Table 1 Prevalence of non-organ specific autoantibodies in anti-HCV positive patients (n = 78).

All serum autoantibodies were determined by indirect immunofluorescence (IFL). A serum dilution of at least 1:40 was considered as a positive result. ANA, anti-nuclear antibodies; SMA, anti-smooth muscle anibodies; AMA, anti-mitochondrial antibodies, ANCA, anti-neutophil-cytoplasmatic antibodies; LKM, anti liver/kidney microsomal antibodies

ISSN: 1471-2334